The inauguration of the Leuna demo plant marks another step forward for Global Bioenergies’ execution strategy. The fab is delivering good yields and the quality of the isobutene is better than expected. The company has also announced that it has received new EU grant funding for adaptation of its second-generation process. The next steps are execution on IBN-ONE, GBE’s first commercial joint venture at an industrial scale, securing financing from 2018 and further commercial licen
22 May 2017
Reaching scale
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Reaching scale
Global Bioenergies SA (ALGBE:PAR) | 0 0 1.6% | Mkt Cap: 77.3m
- Published:
22 May 2017 -
Author:
Catharina Hillenbrand-Saponar -
Pages:
2
The inauguration of the Leuna demo plant marks another step forward for Global Bioenergies’ execution strategy. The fab is delivering good yields and the quality of the isobutene is better than expected. The company has also announced that it has received new EU grant funding for adaptation of its second-generation process. The next steps are execution on IBN-ONE, GBE’s first commercial joint venture at an industrial scale, securing financing from 2018 and further commercial licen